Zacks Initiates Coverage of Enzo Biochem With Neutral RecommendationZacks Investment Research • 06/20/24
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business UpdateGlobeNewsWire • 06/13/24
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateGlobeNewsWire • 03/13/24
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer AppointmentsGlobeNewsWire • 02/01/24
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATEGlobeNewsWire • 12/15/23
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEOGlobeNewsWire • 09/06/23
Enzo Biochem says ransomware attack exposed clinical test data of 2.5 million patientsTechCrunch • 06/01/23
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset SaleGlobeNewsWire • 05/22/23
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 12/12/22